Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
08/23/1995 | EP0667895A1 Detection of selected antigen-antibody reactions |
08/23/1995 | EP0667879A1 A method of surface modification |
08/23/1995 | EP0667786A1 Retro-, inverso-, and retro-inverso synthetic peptide analogues |
08/23/1995 | EP0592596B1 Cover slip holder for bilateral and unilateral simulation of thrombogenesis in partly occluded blood vessels |
08/23/1995 | EP0504196B1 Improvements in and relating to microelectrodes and amperometric assays |
08/23/1995 | EP0500576B1 Outer membrane protein p1 and peptides of haemophilus influenzae type b |
08/23/1995 | CN1029574C Immune percolation checking method and device |
08/23/1995 | CA2142928A1 Method and apparatus for evaluating and/or measuring the permeability of a rock formation |
08/22/1995 | US5444670 Method and apparatus for determining soil strength from Doppler-shifted acoustic signatures |
08/22/1995 | US5444540 Black background inspection apparatus |
08/22/1995 | US5444539 Method of observing liquid for impurities using a transparent container with contrasting colors |
08/22/1995 | US5444527 Imaging flow cytometer for imaging and analyzing particle components in a liquid sample |
08/22/1995 | US5444480 Method of inspecting solid body for foreign matter |
08/22/1995 | US5444435 Halogen monitoring apparatus |
08/22/1995 | US5444367 Method and apparatus for detecting particles in a fluid having coils isolated from external vibrations |
08/22/1995 | US5444161 Substrates for β-galactosidase |
08/22/1995 | US5444158 Merosin, nucleic acids encoding, fragments and uses thereof |
08/22/1995 | US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site |
08/22/1995 | US5443991 Using a carbon dioxide permselective membrane |
08/22/1995 | US5443990 Composition for measuring ionic strength or specific gravity of liquid specimen and test piece prepared from said composition |
08/22/1995 | US5443989 Method for assessing fetal lung maturity using amniotic fluid samples |
08/22/1995 | US5443967 DNA encoding the cancer associated SCM recognition factor |
08/22/1995 | US5443965 Peptide antigens used in diagnosis |
08/22/1995 | US5443962 Methods of identifying inhibitors of cdc25 phosphatase |
08/22/1995 | US5443961 Taking samples from treated and control areas of an individual, establishing marker of keratinocyte cell aging or inflammation, comparing amounts of marker in samples |
08/22/1995 | US5443960 Detection of activated Protein C resistance; screening for thromboembolic diseases |
08/22/1995 | US5443958 2-acrylamine-2-methyl-1-propanesulfonic acid enhancement of alkaline phosphatase label detection |
08/22/1995 | US5443957 Cancer diagnosis |
08/22/1995 | US5443956 Detection, quantitation and classification of RAS proteins in body fluids and tissues |
08/22/1995 | US5443955 Receptor membranes and ionophore gating |
08/22/1995 | US5443954 Immortalized non-tumorigenic human bronchial epithelial cell lines |
08/22/1995 | US5443953 Genetic engineering; diagnosis, therapy |
08/22/1995 | US5443952 Reacting a serum sample with sulfatide and determining the titer of antisulfatide igg and igm antibody that binds to sulfatide to diagnose neuropathy |
08/22/1995 | US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis |
08/22/1995 | US5443794 Measuring apparatus |
08/22/1995 | US5443790 Device for automatically analyzing samples |
08/22/1995 | US5443712 Using an electrolytic cell |
08/22/1995 | US5443710 Graphite, oil and a compound selected from lipids, glycolipids lipoproteins, fatty acid and derivatives, water insoluble species, perfluorosulfonated compounds and salts; used in vivo voltammetric measurement of biogenic chemicals |
08/22/1995 | US5443080 Integrated system for biological fluid constituent analysis |
08/22/1995 | US5442970 Water sampling device |
08/22/1995 | US5442967 Side-stream sampling device |
08/22/1995 | CA2017132C Cold bottom emptying crucible |
08/22/1995 | CA2000473C Apparatus for evaluating quality of raw coffee beans |
08/22/1995 | CA1336763C Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement |
08/22/1995 | CA1336759C Process for the determination of an immunologically detectable substance and a suitable reaction vessel therefor |
08/22/1995 | CA1336758C Piezoelectric specific binding assay with mass amplified reagents |
08/18/1995 | CA2142784A1 Method for assay of biological samples |
08/17/1995 | WO1995022060A1 C-terminal sequencing of peptides which may include proline |
08/17/1995 | WO1995022059A1 Process for labelling acridinium to microparticles and application in an instrument |
08/17/1995 | WO1995022057A1 Bioreagent immobilization medium |
08/17/1995 | WO1995022056A1 Highly specific surfaces for biological reactions, method of preparation and utilization |
08/17/1995 | WO1995022055A1 Ammonia sensor |
08/17/1995 | WO1995022052A1 Detection of lead in blood |
08/17/1995 | WO1995022051A1 Diagnostic flow cell device |
08/17/1995 | WO1995021944A1 Differentially expressed genes in healthy and diseased subjects |
08/17/1995 | WO1995021942A1 Immunoassay kit comprising universal reagents |
08/17/1995 | WO1995021939A1 Method for ordering macromolecules by means of a moving meniscus, and uses thereof |
08/17/1995 | WO1995021938A1 A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c |
08/17/1995 | WO1995021935A1 Method of screening for predisposition to cancer |
08/17/1995 | WO1995021930A2 Method for preparing orphan receptor ligands |
08/17/1995 | WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins |
08/17/1995 | WO1995021923A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor |
08/17/1995 | WO1995021922A2 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
08/17/1995 | WO1995021921A1 Mammalian thymokine genes |
08/17/1995 | WO1995021920A1 Hematopoietic protein and materials and methods for making it |
08/17/1995 | WO1995021917A1 Mammalian cell cycle protein |
08/17/1995 | WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
08/17/1995 | WO1995021912A1 Non-pathogenic strains of hiv-1 |
08/17/1995 | WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain |
08/17/1995 | WO1995021865A1 Immunointeractive molecules-i |
08/17/1995 | WO1995021864A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment |
08/17/1995 | WO1995021861A1 Fk-506 cytosolic binding protein |
08/17/1995 | WO1995021860A1 Methods for variation of chromatin condensation |
08/17/1995 | WO1995021859A1 Cytotoxic factor associated with disseminated sclerosis, its detection and quantification |
08/17/1995 | WO1995021858A2 Mosaic polypeptide and methods for detecting the hepatitis e virus |
08/17/1995 | WO1995021678A1 Filter well and method for its manufacture |
08/17/1995 | WO1995021677A1 Method for the manufacture of filter wells |
08/17/1995 | WO1995021673A1 Preparation and application of artificial anti-idiotypic imprints |
08/17/1995 | WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality |
08/17/1995 | WO1995021627A1 Active immunization using a siderophore receptor protein |
08/17/1995 | WO1995021626A1 Methods for stimulating erythropoiesis using thrombopoietin |
08/17/1995 | WO1995021623A1 Peptides and methods against diabetes |
08/17/1995 | WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
08/17/1995 | WO1995021612A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
08/17/1995 | WO1995021565A1 Apparatus for preventing finger motion during optical measurements |
08/17/1995 | WO1995016040A3 Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form |
08/17/1995 | DE4405553A1 Nicotine determn. in biological media e.g. hair samples |
08/17/1995 | DE4404309A1 Investigation of precipitation of materials from, or solution in, liquids |
08/17/1995 | CA2183362A1 Mosaic polypeptide and methods for detecting the hepatitis e virus |
08/17/1995 | CA2183266A1 Hematopoietic protein and materials and methods for making it |
08/17/1995 | CA2183254A1 Mammalian cell cycle protein |
08/17/1995 | CA2183154A1 Non-pathogenic strains of hiv-1 |
08/17/1995 | CA2183074A1 Detection of lead in blood |
08/17/1995 | CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
08/17/1995 | CA2182978A1 Peptides and methods against diabetes |
08/17/1995 | CA2182977A1 Inducing tolerance with tolerogenic fusion proteins |
08/17/1995 | CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality |
08/17/1995 | CA2182967A1 Production and use of map kinase phosphatases and encoding nucleic acid therefor |
08/17/1995 | CA2182682A1 Immunointeractive molecules-i |
08/17/1995 | CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain |